Dynavax continues to shed staffers as CSO to leave with no replacement plan

Zombie biotech Dynavax Technologies will lose its chief scientific officer in December, but after a host of cuts, it won’t be looking for a new one.

In an 8-K SEC filing today, the California-based biotech said Robert Coffman, Ph.D., “submitted notice of his retirement from the company, effective December 1, 2019.”